Corporate Reputation of Pharma in 2018: The Patient Perspective of Autoimmune Patient Groups - ResearchAndMarkets.com

DUBLIN--()--The "The Corporate Reputation of Pharma in 2018 - The Patient Perspective - Autoimmune Edition: The Views of 190 Autoimmune Patient Groups" report has been added to ResearchAndMarkets.com's offering.

To enable comparisons with historical data, 2017's autoimmune corporate-reputation results (which were not published as a stand-alone report) have been included in this 2018 autoimmune report.

The 2018 results are drawn from a survey of patient groups, conducted November 2018 - February 2019.

Profile of 2018's respondent autoimmune patient groups: 190 autoimmune patient groups, including those specialising in: ankylosing spondylitis [15 respondent patient groups], atopic dermatitis/eczema [2], coeliac [11], Crohn's/ulcerative colitis [25], lupus [15], plaque psoriasis [27], psoriatic arthritis [3], rheumatoid arthritis [30], scleroderma [10], all types of arthritis [22] and other autoimmune conditions [30].

From 48 countries.

66% are national patient groups. 7% are international patient groups.

Patient-group partnerships with industry: 66% of the 190 respondent autoimmune patient groups worked/partnered with at least one pharma company.

Company analyses: 35 pharma companies were analysed by the 190 autoimmune patient groups for overall corporate reputation, and for performance at 12 individual indicators of corporate reputation.

The 2018 autoimmune corporate-reputation report contains three appendices:

  • Appendix 1. Analyses of corporate reputation in the field of arthritis, 2018 v. 2017.
  • Appendix 2. Analyses of corporate reputation in the field of psoriasis, 2018 v. 2017. And ...
  • Appendix 3: Comments from 2018's respondent autoimmune patient groups on how pharma can improve (organised by country and condition).

Key Topics Covered:

  1. Executive Summary
  2. Autoimmune Patient-Group Relationships With Pharma, 2018
  3. Rankings Of 35 Pharma Companies, 2018 V. 2017 Among Autoimmune Patient Groups Familiar With The Companies
  4. Rankings Of 19 Pharma Companies, 2018 V. 2017 Among Autoimmune Patient-Group Partners
  5. Profiles Of The 35 Companies, 2018 V. 2017

Appendices

I. The Corporate Reputation Of Pharma In 2018 - The Views Of 55 Arthritis Patient Groups

II. The Corporate Reputation Of Pharma In 2018 - The Views Of 27 Psoriasis Patient Groups

III What 190 Autoimmune Patient Groups Say On Pharma(And How The Industry Can Improve)

Companies Mentioned

  • AbbVie
  • Allergan
  • Almirall
  • Amgen
  • Astellas
  • AstraZeneca
  • Bayer
  • Behring
  • Biogen
  • Boehringer
  • Bristol-Myers
  • CSL
  • Celgene
  • Chiesi
  • Eli Lilly
  • Fabre
  • Farmaceutici
  • Ferring
  • GSK
  • Gilead
  • Grnenthal
  • Ingelheim
  • Janssen
  • KGaA
  • LEO
  • Menarini
  • Merck & Co/MSD
  • Mundipharma
  • Nordisk
  • Novartis
  • Novo
  • Octapharma
  • Pfizer
  • Pharma
  • Pierre
  • Roche/Genentech
  • Sanofi
  • Servier
  • Squibb
  • Takeda/Shire
  • Teva
  • UCB

For more information about this report visit https://www.researchandmarkets.com/r/hpa6b8

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900